Check what supports each statement: experiments, reported results, scope, and limitations.Know what the science actually supports before you trust the answer.
Press Enter ↵ to review paper
Explore by Goal
"Science knows no country, because knowledge belongs to humanity, and is the torch which illuminates the world."
- Louis Pasteur
Quick Explanation
Copied
Claim-to-evidence check (HtrA1 → EMT/EMT markers in HCC)
Evidence provided: HtrA1 mRNA is lower in HCC vs normal liver; HtrA1 decreases with increasing lymph-node metastasis category; higher HtrA1 associates with better postoperative survival probability (5-year follow-up) in this cohort of n=60 patients.
Mechanistic direction (in vitro): siRNA-mediated HtrA1 knockdown in HepG2 increases migration and shifts EMT markers toward EMT (↓E-cadherin, ↑vimentin), while pcDNA-HtrA1 overexpression in MHCC97H shows the opposite EMT marker/migration direction.
Clinical correlation (tissue EMT markers): across 60 tumor tissues, HtrA1 shows positive correlation with E-cadherin (reported R²=0.5903, P<0.001) and negative correlation with vimentin (reported R²=0.6067, P<0.001).
Key skeptical note: clinical correlations do not prove causality; in vitro is limited to two HCC cell lines and a migration/marker panel (no invasion, no EMT functional states beyond E-cadherin/vimentin).
Long Explanation
Paper review (skeptical, evidence-first): “HtrA1 regulates epithelial–mesenchymal transition in hepatocellular carcinoma”
Primary claim: HtrA1 behaves as a tumor-suppressive factor in HCC by inhibiting EMT-associated marker changes and migration, with HtrA1 loss correlating with lymph-node metastasis category and poorer EMT-marker alignment in patient tissues.
1) Study design map (what was measured)
What supports this map: the manuscript states patient cohort (n=60) with qPCR/clinical categories and survival follow-up; plus in vitro transfection in HepG2 (siRNA) and MHCC97H (pcDNA) followed by Transwell migration and E-cadherin/vimentin qPCR and Western blot.
2) Patient cohort: lymph-node stratification & survival association
The manuscript reports n=60 HCC patients and breaks down lymph node involvement as N0=14, N1–N3=28, NX=18.
Direction of association (no raw numeric HtrA1 values provided)
HtrA1 expression in tumor tissues is reported as decreased vs normal hepatic tissue.
Within patients, HtrA1 is reported highest in lymph-node-negative and lowest in the “>4 lymph nodes metastasis” group (the abstract frames this, and the text references Fig.1B as such).
Patients with high HtrA1 expression have higher postoperative survival probability up to ~58 months in the plotted follow-up.
3) In vitro perturbation: migration phenotype
The manuscript reports: (i) si-HtrA1 knockdown in HepG2 significantly increases Transwell migration; (ii) pcDNA-HtrA1 overexpression in MHCC97H significantly decreases migration.
4) EMT marker logic: E-cadherin & vimentin
The manuscript reports that HtrA1 down-regulation in HepG2 decreases E-cadherin and increases vimentin (mRNA and protein), while HtrA1 up-regulation in MHCC97H increases E-cadherin and decreases vimentin (mRNA and protein).
The manuscript reports: HtrA1 positively related to E-cadherin (R²=0.5903, P<0.001) and negatively correlated with vimentin (R²=0.6067, P<0.001) in 60 tumor tissues.
Skeptical interpretation: R² values suggest fairly strong linear association, but the clinical correlation is not causality (shared confounding by tumor subtype, microenvironment, or stage is possible). Also, R² from Pearson correlation usually implies r²; the manuscript labels R² explicitly, but it does not provide scatter data, effect sizes by subgroup, or multiple-testing adjustments.
6) Mechanistic claims: what is supported vs not supported
Supported directionally by this paper’s assays
HtrA1 perturbation shifts an EMT marker panel (E-cadherin and vimentin at mRNA and protein levels) in opposite directions depending on knockdown vs overexpression, in HepG2 vs MHCC97H.
HtrA1 perturbation alters migration in a Transwell migration setup with knockdown increasing migration in HepG2 and overexpression decreasing migration in MHCC97H.
Clinical association between HtrA1 and EMT marker levels is reported as significant Pearson correlations.
Not demonstrated (important blind spots)
No direct causal mechanism is shown linking HtrA1 protease activity or specific signaling pathways to EMT transcriptional programs; the paper primarily measures a marker panel and migration.
EMT is operationalized narrowly using only E-cadherin and vimentin; EMT is multi-dimensional (additional markers, functional EMT criteria, and cell state heterogeneity are not presented in the excerpt).
Clinical causality not established: correlations in tumor tissues can reflect stage, aggressiveness, or co-regulation rather than HtrA1 acting upstream.
Reproducibility concern: the provided study metadata notes that data availability is not provided in the manuscript; this constrains independent re-analysis.
This chart is not extracted quantitative effect-size evidence; it’s a heuristic visualization reflecting how clearly each claim element is stated and supported by the provided sections (abstract/results/methods) of the paper text.
8) What would most disprove/reshape this conclusion?
If additional HCC lines (independent from HepG2/MHCC97H) show no consistent EMT-marker shift or migration effect after HtrA1 knockdown/overexpression, the generality of the proposed regulatory role weakens.
If multivariable clinical modeling (adjusting for tumor size, WHO grade, metastasis status, KPS, etc.) shows that HtrA1–EMT marker associations disappear, then the marker correlation may be stage-confounded rather than mechanistically upstream.
If mechanistic experiments targeting HtrA1 enzymatic activity or intervening signaling pathways show no effect on EMT markers beyond off-target effects of transfection, the causal direction would be challenged.
Explore author-specific perspectives on HtrA1/EMT/HCC
Feedback:
Updated: March 21, 2026
BGPT Paper Review
Study Novelty
60%
The paper links HtrA1 to EMT marker shifts and migration in a specific cancer context (HCC) using a relatively straightforward perturbation-and-marker approach; this is incremental rather than paradigm-shifting.
Scientific Quality
60%
Moderate quality: clear directional results with multiple HtrA1 perturbations (three siRNAs) and concordant marker readouts (qPCR + Western) plus clinical correlations. However, mechanistic depth is limited in the provided text, EMT is assessed with only two canonical markers, and reproducibility is constrained by lack of explicit data availability.
Study Generality
50%
Generality is constrained by use of only two HCC cell lines and a single biomarker panel (E-cadherin/vimentin), plus a single institution cohort.
Study Usefulness
60%
Useful as a hypothesis-generating link between HtrA1 expression and EMT-associated phenotypes in HCC, but it does not yet establish pathway-level causality or broader EMT state characterization.
Study Reproducibility
50%
Reproducibility is limited by missing explicit public data availability/accession info in the manuscript text provided, and by incomplete quantitative details in the excerpt (e.g., not all supplementary numeric values are shown here).
Explanatory Depth
60%
The paper supports an association/functional direction (HtrA1 loss → EMT marker shift → migration increase), but it does not present direct mechanistic experiments (e.g., HtrA1 activity dependence or pathway-specific EMT transcription factor readouts) in the provided text.
Construct a correlation visualization using the reported R²/P values from the 60-patient tissue dataset, then generate a directional EMT/migration summary chart from the reported in vitro perturbation outcomes.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
The “HtrA1 → EMT” claim as a direct cause of EMT is weaker if additional EMT markers (beyond E-cadherin/vimentin) do not track with HtrA1 levels; in that case the observed marker shifts may be a downstream consequence of altered proliferation/stress rather than EMT itself.
A simple model where HtrA1 only affects migration independent of EMT is less likely if EMT-marker dynamics robustly predict migration direction across perturbations; however, if migration changes persist when EMT markers are forced to remain constant, the EMT-centered model would fall.
Explore by Goal
Quick Explanation
Long Explanation
Top Data Sources
Ask a Follow-Up
Key Insight
Analysis 
Hypothesis Graveyard
Potential Experiments
Discussion